Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07247240 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy of Inhaled Nitric Oxide in Congenital Diaphragmatic Hernia

Study acronym: INOCDH
StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Asan Medical Center
92 trials monitored
See 1 trial at risk
Hypertension
1,925 trials monitored
See 99 trials at risk
This multicenter, prospective, single-arm study aims to evaluate the efficacy of inhaled nitric oxide (iNO) in neonates with congenital diaphragmatic hernia (CDH) and early pulmonary hypertension. Short-term treatment response will be assessed by the changes in oxygenation index and other parameters including echocardiographic parameters at predefined intervals.
Trial Details
NCT Number NCT07247240
Lead Sponsor Asan Medical Center
Collaborators: Seoul National University Hospital, Severance Hospital, Chungnam National University Hospital
Conditions
(from sponsor)		 Congenital Diaphragmatic Hernia, Pulmonary Hypertension
Related terms Hernias, Diaphragmatic, Congenital, Hypertension, Pulmonary
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov